What about their margins, seems pretty steep to me: 2016 Total Revenue: $18,318,567 2016 net income: $209,319 That's about a 2016 EPS of .00056 at let's say today's share price of .17 per share price that's X30,357 forward earnings... To say "RXMD isn't going anywhere but up" is simply ludicrous.